243 related articles for article (PubMed ID: 22040304)
1. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.
Jee D; Lee WK
Curr Eye Res; 2012 May; 37(5):408-15. PubMed ID: 22040304
[TBL] [Abstract][Full Text] [Related]
2. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.
Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L; Rehak M
Ophthalmic Res; 2012; 47(3):157-62. PubMed ID: 22116547
[TBL] [Abstract][Full Text] [Related]
4. Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits.
Cam D; Berk AT; Micili SC; Kume T; Ergur BU; Yilmaz O
Curr Eye Res; 2017 Feb; 42(2):315-322. PubMed ID: 27314606
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats.
Kim EC; Lee WS; Kim MS
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4569-73. PubMed ID: 20393106
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of apoptotic activity in photoreceptor cells after intravitreal injection of bevacizumab and pegaptanib sodium in rabbits.
Avci B; Avci R; Inan UU; Kaderli B
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3438-46. PubMed ID: 19255151
[TBL] [Abstract][Full Text] [Related]
8. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury.
Abcouwer SF; Lin CM; Wolpert EB; Shanmugam S; Schaefer EW; Freeman WM; Barber AJ; Antonetti DA
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5920-33. PubMed ID: 20554620
[TBL] [Abstract][Full Text] [Related]
9. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
[TBL] [Abstract][Full Text] [Related]
10. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravitreal bevacizumab in repeated doses: an experimental study.
Sari A; Adiguzel U; Canacankatan N; Yilmaz N; Dinc E; Oz O
Retina; 2009 Oct; 29(9):1346-55. PubMed ID: 19934825
[TBL] [Abstract][Full Text] [Related]
12. Safety of intravitreal bevacizumab in the developing rabbit retina.
Zayit-Soudry S; Zemel E; Barak A; Perlman I; Loewenstein A
Retina; 2011 Oct; 31(9):1885-95. PubMed ID: 21799464
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
14. Retinal function and morphology in rabbit after intravitreal injection of VEGF inhibitors.
Myers AC; Lövestam Adrian M; Bruun A; Ghosh F; Andréasson S; Ponjavic V
Curr Eye Res; 2012 May; 37(5):399-407. PubMed ID: 22510009
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
Matsuyama K; Ogata N; Matsuoka M; Wada M; Nishimura T; Takahashi K
J Ocul Pharmacol Ther; 2011 Aug; 27(4):379-83. PubMed ID: 21810018
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
Ma Y; Zhang Y; Zhao T; Jiang YR
Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of bevacizumab treatment on newborn rat retinal cell proliferation, death, and differentiation.
Miguel NC; Matsuda M; Portes AL; Allodi S; Mendez-Otero R; Puntar T; Sholl-Franco A; Krempel PG; Monteiro ML
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7904-11. PubMed ID: 23139275
[TBL] [Abstract][Full Text] [Related]
18. Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes.
Wu WC; Lai CC; Chen KJ; Chen TL; Wang NK; Hwang YS; Yeung L; Li LM
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3701-8. PubMed ID: 20181842
[TBL] [Abstract][Full Text] [Related]
19. NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.
Rocco ML; Balzamino BO; Esposito G; Petrella C; Aloe L; Micera A
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):567-574. PubMed ID: 28013393
[TBL] [Abstract][Full Text] [Related]
20. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
